Mexican Researchers Decry Lack of Support

MEXICO CITY—A recent decision by Mexico's federal government to boost R&D spending has failed to stem growing dissatisfaction in the scientific community here over the lack of public support for science and technology. The government said last month it is diverting 5 billion pesos ($3.8 million) from other public programs to the National Science and Technology Research Council (CONACYT). Half of the supplemental funds are to be used for scientific research and half for technological develo

Written byPetra Fischer
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The government said last month it is diverting 5 billion pesos ($3.8 million) from other public programs to the National Science and Technology Research Council (CONACYT). Half of the supplemental funds are to be used for scientific research and half for technological development.

But reaction in the scientific community has been restrained. The new funds do little to close the gap between the $6 million budgeted this year for scientific and technological research projects managed by CONACYT and, for example, the $20 million budgeted in 1981, before Mexico's economy was buffeted by the devalued peso and the worldwide oil glut.

"A drop in the bucket," a CONACYT administrator scoffed. "The answer to science and technology development problems quite obviously is not to wait for more money from above, but to look more and more to the private sector for support."

Between 1970 and 1980, Mexico increased its science and technology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies